To this end, we categorized tumors as CD4high or CD4low (=<median of % CD4+ T cells in tumor) and fit logistic regression models to predict T cell infiltration by the CD4+ T cell clusters (in PBMCs) that we had identified by unsupervised CyTOF analysis (Fig. 4). The gene discussed is CD4; the disease is neoplasm.